Ameriprise’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.17M | Sell |
38,474
-27,042
| -41% | -$1.76M | ﹤0.01% | 2917 |
|
|
2025
Q4 | $5.25M | Sell |
65,516
-11,879
| -15% | -$798K | ﹤0.01% | 2393 |
|
|
2025
Q3 | $3.77M | Sell |
77,395
-616
| -0.8% | -$38.1K | ﹤0.01% | 2632 |
|
|
2025
Q2 | $5.82M | Sell |
78,011
-4,955
| -6% | -$328K | ﹤0.01% | 2246 |
|
|
2025
Q1 | $5.27M | Sell |
82,966
-19,709
| -19% | -$1.34M | ﹤0.01% | 2272 |
|
|
2024
Q4 | $8.02M | Sell |
102,675
-132,854
| -56% | -$10.7M | ﹤0.01% | 1982 |
|
|
2024
Q3 | $18.9M | Buy |
235,529
+6,032
| +3% | +$487K | ﹤0.01% | 1366 |
|
|
2024
Q2 | $19M | Sell |
229,497
-43,003
| -16% | -$3.78M | 0.01% | 1312 |
|
|
2024
Q1 | $23.3M | Sell |
272,500
-14,560
| -5% | -$1.14M | 0.01% | 1216 |
|
|
2023
Q4 | $24.5M | Sell |
287,060
-99,746
| -26% | -$8.62M | 0.01% | 1143 |
|
|
2023
Q3 | $34.6M | Sell |
386,806
-1,233
| -0.3% | -$110K | 0.01% | 913 |
|
|
2023
Q2 | $33M | Sell |
388,039
-72,203
| -16% | -$6.1M | 0.01% | 965 |
|
|
2023
Q1 | $38.1M | Buy |
460,242
+14,366
| +3% | +$1.16M | 0.01% | 888 |
|
|
2022
Q4 | $35.1M | Sell |
445,876
-7,322
| -2% | -$589K | 0.01% | 889 |
|
|
2022
Q3 | $33.6M | Buy |
453,198
+55,121
| +14% | +$3.96M | 0.01% | 867 |
|
|
2022
Q2 | $25.9M | Buy |
398,077
+224,492
| +129% | +$13.3M | 0.01% | 1039 |
|
|
2022
Q1 | $11M | Buy |
173,585
+102,015
| +143% | +$5.55M | ﹤0.01% | 1848 |
|
|
2021
Q4 | $3.79M | Sell |
71,570
-2,404
| -3% | -$146K | ﹤0.01% | 2660 |
|
|
2021
Q3 | $5.22M | Sell |
73,974
-36,216
| -33% | -$2.29M | ﹤0.01% | 2364 |
|
|
2021
Q2 | $7.34M | Sell |
110,190
-645,234
| -85% | -$45.7M | ﹤0.01% | 2169 |
|
|
2021
Q1 | $83.9M | Buy |
755,424
+96,006
| +15% | +$11.9M | 0.03% | 569 |
|
|
2020
Q4 | $78.3M | Buy |
659,418
+173,686
| +36% | +$18.7M | 0.03% | 558 |
|
|
2020
Q3 | $42.4M | Buy |
485,732
+64,746
| +15% | +$5.66M | 0.02% | 704 |
|
|
2020
Q2 | $37.7M | Buy |
420,986
+31,254
| +8% | +$3.16M | 0.02% | 724 |
|
|
2020
Q1 | $38.8M | Buy |
389,732
+276,340
| +244% | +$30M | 0.02% | 641 |
|
|
2019
Q4 | $13M | Sell |
113,392
-13,519
| -11% | -$1.64M | 0.01% | 1527 |
|
|
2019
Q3 | $16M | Sell |
126,911
-12,516
| -9% | -$1.59M | 0.01% | 1317 |
|
|
2019
Q2 | $16.8M | Sell |
139,427
-231,732
| -62% | -$22.8M | 0.01% | 1298 |
|
|
2019
Q1 | $32.5M | Sell |
371,159
-64,252
| -15% | -$5.84M | 0.01% | 864 |
|
|
2018
Q4 | $43.6M | Buy |
435,411
+9,264
| +2% | +$973K | 0.02% | 673 |
|
|
2018
Q3 | $48.8M | Sell |
426,147
-229,627
| -35% | -$23.8M | 0.02% | 762 |
|
|
2018
Q2 | $58.8M | Sell |
655,774
-578,215
| -47% | -$48.8M | 0.03% | 595 |
|
|
2018
Q1 | $90.3M | Buy |
1,233,989
+678,660
| +122% | +$46.6M | 0.04% | 416 |
|
|
2017
Q4 | $32.3M | Sell |
555,329
-23,388
| -4% | -$1.23M | 0.01% | 784 |
|
|
2017
Q3 | $26M | Buy |
578,717
+201
| +0% | +$8.35K | 0.01% | 884 |
|
|
2017
Q2 | $22.8M | Buy |
578,516
+102,950
| +22% | +$4.23M | 0.01% | 936 |
|
|
2017
Q1 | $19.3M | Buy |
475,566
+140,500
| +42% | +$5.49M | 0.01% | 1041 |
|
|
2016
Q4 | $13.5M | Sell |
335,066
-3,711
| -1% | -$140K | 0.01% | 1276 |
|
|
2016
Q3 | $12.3M | Buy |
338,777
+22,466
| +7% | +$771K | 0.01% | 1290 |
|
|
2016
Q2 | $9.17M | Buy |
316,311
+24,245
| +8% | +$733K | 0.01% | 1460 |
|
|
2016
Q1 | $10.2M | Sell |
292,066
-222,851
| -43% | -$7.2M | 0.01% | 1399 |
|
|
2015
Q4 | $16.6M | Sell |
514,917
-111,902
| -18% | -$3.63M | 0.01% | 1045 |
|
|
2015
Q3 | $20.3M | Sell |
626,819
-227,585
| -27% | -$8.56M | 0.01% | 933 |
|
|
2015
Q2 | $35.3M | Buy |
854,404
+69,178
| +9% | +$2.92M | 0.02% | 666 |
|
|
2015
Q1 | $35.3M | Buy |
785,226
+37,470
| +5% | +$1.57M | 0.02% | 680 |
|
|
2014
Q4 | $28M | Sell |
747,756
-122,896
| -14% | -$4.5M | 0.02% | 769 |
|
|
2014
Q3 | $30.4M | Sell |
870,652
-58,935
| -6% | -$2.1M | 0.02% | 728 |
|
|
2014
Q2 | $32.8M | Sell |
929,587
-14,002
| -1% | -$468K | 0.02% | 732 |
|
|
2014
Q1 | $30.8M | Buy |
943,589
+415,942
| +79% | +$15.9M | 0.02% | 756 |
|
|
2013
Q4 | $22.2M | Buy |
527,647
+136,279
| +35% | +$5.61M | 0.01% | 935 |
|
|
2013
Q3 | $15.6M | Buy |
391,368
+2,181
| +0.6% | +$91.5K | 0.01% | 1146 |
|
|
2013
Q2 | $16.1M | Buy |
+389,187
| New | +$15.8M | 0.01% | 1115 |
|
Other funds holding HAE
VPM
VCM
RRAM
Ameriprise's HAE Position: Q1 2026 in Review
Ameriprise reduced its Haemonetics (HAE) stake by 41% in Q1 2026, selling an estimated $1.76M and leaving 38,474 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2917.
Ameriprise first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $90.3M in Q1 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Ameriprise held 38,474 shares of Haemonetics worth $2.17M as of Q1 2026.
- Ameriprise sold 27,042 Haemonetics shares in Q1 2026, an estimated $1.76M.
- Haemonetics made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2917 holding.
- Ameriprise first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Haemonetics position peaked at $90.3M in Q1 2018.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.